AzTrials
AzTrials

Surgical Site InfectionNCT03854370

Vaginal Prep Solutions to Reduce Bacteria Colony Counts in Patients Having a Vaginal Surgery

A study testing Betadine, Peridex and TechniCare in people with Surgical Site Infection and Vaginal Surgery, run by Wright State University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is a randomized trial comparing the effectiveness of 4 vaginal prep solutions (betadine, baby shampoo, TechniCare and Peridex) on reducing bacterial colony counts during surgery preparation. Women undergoing a vaginal surgery will be enrolled into the trial prior to surgery. Read more about this study

Who is it for?
Ages 18 to 90 years, women only
Conditions the study is for
Surgical Site Infection, Vaginal Surgery
What is being tested?
Betadine, Peridex and TechniCare
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
35 participants
Where
1 siteUnited States
Study dates
21 Jun 2019to 1 Jan 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All procedures that require a vaginal incision will be included in the study, these being procedures like hysterectomies and reconstruction surgery.

Who cannot join

  • Non-incisional procedures like dilation and curettage will be excluded.
  • Revision surgeries will also be excluded to decrease any complications.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wright State Physicians

    Dayton, Ohio, 45409

Other trials in United States

About this study

Official title: A Randomized Trial of Vaginal Prep Solutions to Reduce Bacteria Colony Counts in Patients Having a Vaginal Surgery

This is a randomized trial comparing the effectiveness of 4 vaginal prep solutions (betadine, baby shampoo, TechniCare and Peridex) on reducing bacterial colony counts during surgery preparation. Women undergoing a vaginal surgery will be enrolled into the trial prior to surgery. Target sample size per group is 15 patients. During standard surgical prep, a vaginal swab will be taken to assess the initial colony counts for aerobic and anaerobic bacteria. After the initial swab, the incision point will be prepared using one of the prep 4 solutions (betadine, baby shampoo, TechniCare or Peridex). After a predefined 10 minutes, the area will be re-swabbed to determine pre-incision colony counts. A third swab will be collected after incision closure. Laboratory analyses for raw colony counts, sensitivities, identification (using MALDI-TOF) will be performed. The results are expected to show that there will be reduced colony counts at the pre-incision point with baby shampoo having the least reduction, followed by betadine and TechniCare, then Peridex. Patient reported outcomes for vaginal itching and burning as well as patient report of any treatment for vaginal infection will be collected by telephone at 2 days, 2 weeks and 1 month post-surgery.

Read the detailed description

BACKGROUND AND LITERATURE REVIEW Antiseptic preparation for surgical incision sites has greatly reduced postoperative infections. However, surgical site infections (SSI) are still the leading cause of hospitalizations after surgery. With the application of antiseptic preparation, a reduction in bacterial counts follows. The rate at which the bacterial counts rise between preparation and incision may be of variation depending on the surgical antiseptic scrub.

Betadine (Povidone- iodine), Peridex (Chlorhexidine), baby shampoo and TechniCare (chloroxynel) are all surgical scrubs approved for the preparation of vaginal access surgeries. While there has been controversy on the use of Chlorohexidine for vaginal preparation surgery, due to its labeling as a cause for irritation, studies have shown that when 2-4% Chlorhexidine is used in the vaginal area there are little to no signs of irritation and the bacteria counts post incision are less than the bacterial counts for povidone iodine1,2. Baby shampoo can also be used as an effective antiseptic scrub with no irritation and no statistical difference in bacterial count reduction as compared to povidone-iodine3. Little research has been done to look at the antiseptic power of Chloroxynel in vaginal surgeries. However, when used as a root canal antiseptic it can reduce bacteria counts by 99.9%4. This is illustrative of its capability to reduce bacteria on a mucus membrane similar to the vagina.

There is literature that shows the antiseptic power of Betadine, Peridex, Baby shampoo and TechniCare for post-incisional bacteria counts, but little is known about the pre-incisional power of these scrubs for vaginal access surgeries.

SPECIFIC AIMS OR OBJECTIVES The aim of this study is to understand the power of vaginal surgical scrubs before incision. This will be done by collecting bacterial samples both before and 10 minutes after antiseptic preparation and after incision closure, along with follow-up data of irritation, infection post-surgery, and infection risk factors of each patient.

SIGNIFICANCE TO PATIENT, INSTITUTION, PROFESSION, OR ALL Vaginal preparation research provides benefitted knowledge to hospitals and physicians in the prevention of surgical site infections (SSI). This specific project will provide insight regarding the bacteria-eliminating power of four different surgical scrubs used on the vaginal mucous membrane, pre-incision. There is potential for this study to determine the most effective scrub for vaginal surgeries, as well as correlate pre-incisional bacterial counts and the post-procedure bacterial counts with likelihood of surgical site infections. The information collected from this study could benefit future patients and hospitals alike in terms of reducing the risk of SSI's. The risks of this study could be unidentified allergies to any of the surgical scrubs, or a loss of patient data. These are unlikely risks due to the protocol of the study.

METHODS This study will use block randomization. There will be four arms of the study one for each of the four surgical scrubs. There will be approximately 15 patients per arm. Patients undergoing vaginal surgeries will be recruited from Wright State Physicians Obstetrics and Gynecology. All procedures that require a vaginal incision will be included in the study, these being procedures like hysterectomies and reconstruction surgery. Non-incisional procedures like dilation and curettage will be excluded. Revision surgeries will also be excluded to decrease any complications. Patients who consent to the study will be given a ID and will be randomly assigned to one of the four arms. Patients will be excluded if an allergy to any of the scrubs is listed or found. Each recruited patient will be over the age of 18 with ability to provide consent.

Each patient will be given a standard prophylaxis 30 minutes before surgery. After prophylaxis administration and before surgical antiseptic preparation, a one minute swab will be taken of the vagina making sure to span the surface area of the vaginal canal with avoidance of the cervix. The swab will then be broken off into a tube labeled with the patient ID, date, and "pre-scrub". The patient will then undergo antiseptic preparation with the assigned surgical prep. A standard procedure of application will be done for each of the arms. Ten minutes after application, another swab will be taken using the same procedure as the "pre-scrub" swab. This swab will be broken off in a tube labeled with the patient ID, date, and "post-scrub"1. After incision closure, a third swab will be taken and will be labeled 'post-procedure'. The swabs will then be transported to CompuNet for analysis of aerobic, anaerobic bacteria and fungal colonies using Matrix Assisted Depolarization/Ionization Time of Flight mass spectrometry (MADI-TOF).

The data of colony counts will be collected from CompuNet. BMI, age, prophylaxis, postmenopausal information, diabetic information, smoking history, surgical duration, complication in surgery, and length of hospital stay will all be collected from patient records. No patient identifiers will be collected5. Patients will be followed up after surgery approximately two days, two weeks and a month after surgery to get information on irritation and/or surgical infection. This data will be collected either be phone call or at post-surgical follow-up appointment at Wright State Physicians. The South Hampton Grading Scheme for Surgical Wounds will be used to Quantify Each patients level of irritation and/or infection. The scale is a Zero to Five score, with Zero being no irritation or infection and Five being severe irritation or infection15.

One potential obstacle of this study could be recruitment of patients. Patients will not be given incentive for participation and will not acquire any direct benefit from the study. Another potential issue may arise from the size of the study; there may not be enough subjects recruited for each arm of the study to find a detectable and significant difference in the use of one surgical scrub over another.

Precautions will need to be taken for allergies. A recruited patient may not be aware of personal allergies to the surgical scrubs. This would put the patient at risk of harm if there was the potential for having an allergy to the assigned scrub. Since data will be collected from the patient's medical records, precautions will be taken to avoid loss of patient identifiers. All research investigators will only utilize the patients assigned research ID. This will both protect the patient and avoid bias.

Being tested
Baby shampoo, Betadine, Peridex, TechniCare
Keywords
surgical prep, vaginal prep, baby shampoo
Medical subject headings
Surgical Wound Infection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baby shampooOther

    baby shampoo will be used to prepare the surgical site prior to incision

  • BetadineOther

    Also called Povidone- iodine

    Betadine (Povidone- iodine) will be used to prepare the surgical site prior to incision

  • PeridexOther

    Also called Chlorhexidine

    Peridex (Chlorhexidine) will be used to prepare the surgical site prior to incision

  • TechniCareOther

    Also called chloroxynel

    TechniCare (chloroxynel) will be used to prepare the surgical site prior to incision

Study groups in NCT03854370
Study groupRoleWhat they receive
Baby shampooExperimentalBaby shampoo used for surgical site prep
Receives: Other: Baby shampoo
Peridex (Chlorhexidine)Active comparatorPeridex used for surgical site prep
Receives: Other: Peridex
TechniCare (chloroxynel)Active comparatorTechniCare used for surgical site prep
Receives: Other: TechniCare
Betadine (Povidone- iodine)Active comparatorBetadine used for surgical site prep
Receives: Other: Betadine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vaginal Colony Counts (Anaerobic)

    anaerobic culture colony counts - change in anaerobic colony counts from prior to surgical prep to 10 minutes after surgical prep

    Measured: 2 timepoints: prior to surgical prep, and 10 min after surgical prep

  2. Vaginal Colony Counts (Aerobic)

    aerobic culture colony counts - change in aerobic colony counts from prior to surgical prep to 10 minutes after surgical prep

    Measured: 2 timepoints: prior to surgical prep, and 10 min after surgical prep

Secondary outcomes (4)
  1. Vaginal Colony Counts (Fungal)

    fungal culture colony counts - change in fungal colony counts from prior to surgical prep to 10 minutes after surgical prep

    Measured: 2 timepoints: prior to surgical prep, and 10 min after surgical prep

  2. Vaginal Colony Counts (Anaerobic)

    Change in anaerobic culture colony counts from 10 min after surgical prep (prior to incision) to post-procedure (incision closure)

    Measured: 2 timepoints: 10 min after surgical prep (prior to incision), and after incision closure

  3. Vaginal Colony Counts (Aerobic)

    Change in aerobic culture colony counts from 10 min after surgical prep (prior to incision) to post-procedure (incision closure)

    Measured: 2 timepoints: 10 min after surgical prep (prior to incision), and after incision closure

  4. Vaginal Colony Counts (Fungal)

    Change in fungal culture colony counts from 10 min after surgical prep (prior to incision) to post-procedure (incision closure)

    Measured: 2 timepoints: 10 min after surgical prep (prior to incision), and after incision closure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2019
  2. Study start21 Jun 2019
  3. Primary completion30 Sep 2023
  4. Study completion1 Jan 2024

Why it stopped: COVID impact on recruitment; challenges with enrollment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized to 1 of 4 surgical prep agents
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03854370
Sponsor's protocol ID
06612
Status last verified
Oct 2024
First submitted
18 Jan 2019
Last updated
30 Oct 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be shared on a case by case basis

Publications

  • Culligan PJ, Kubik K, Murphy M, Blackwell L, Snyder J. A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol. 2005 Feb;192(2):422-5. doi: 10.1016/j.ajog.2004.08.010.

    PubMed 15695981
  • Al-Niaimi A, Rice LW, Shitanshu U, Garvens B, Fitzgerald M, Zerbel S, Safdar N. Safety and tolerability of chlorhexidine gluconate (2%) as a vaginal operative preparation in patients undergoing gynecologic surgery. Am J Infect Control. 2016 Sep 1;44(9):996-8. doi: 10.1016/j.ajic.2016.02.036. Epub 2016 May 24.

    PubMed 27234011
  • Garcia GA, Nguyen CV, Yonkers MA, Tao JP. Baby Shampoo Versus Povidone-Iodine or Isopropyl Alcohol in Reducing Eyelid Skin Bacterial Load. Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb;34(1):43-48. doi: 10.1097/IOP.0000000000000850.

    PubMed 28072611
  • Lewis LA, Lathi RB, Crochet P, Nezhat C. Preoperative vaginal preparation with baby shampoo compared with povidone-iodine before gynecologic procedures. J Minim Invasive Gynecol. 2007 Nov-Dec;14(6):736-9. doi: 10.1016/j.jmig.2007.05.010.

    PubMed 17980335
  • Schafer E, Bossmann K. Antimicrobial efficacy of chloroxylenol and chlorhexidine in the treatment of infected root canals. Am J Dent. 2001 Aug;14(4):233-7.

    PubMed 11699743
  • American College of Obstetricians and Gynecologists Women's Health Care Physicians; Committee on Gynecologic Practice. Committee Opinion No. 571: Solutions for surgical preparation of the vagina. Obstet Gynecol. 2013 Sep;122(3):718-20. doi: 10.1097/01.AOG.0000433982.36184.95.

    PubMed 23963423
  • Van Wicklin SA. Preoperative vaginal preps with chlorhexidine gluconate solution. Am J Obstet Gynecol. 2006 Aug;195(2):624; author reply 625. doi: 10.1016/j.ajog.2005.11.002. Epub 2006 Apr 21. No abstract available.

    PubMed 16890564
  • Vorherr H, Ulrich JA, Messer RH, Hurwitz EB. Antimicrobial effect of chlorhexidine on bacteria of groin, perineum and vagina. J Reprod Med. 1980 Apr;24(4):153-7.

    PubMed 7373599
  • Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control. 1988 Aug;16(4):173-7. doi: 10.1016/0196-6553(88)90029-6.

    PubMed 3189943
  • Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, Banerjee SN, Edwards JR, Tolson JS, Henderson TS, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):152S-157S. doi: 10.1016/0002-9343(91)90361-z.

    PubMed 1656747
  • Faro C, Faro S. Postoperative pelvic infections. Infect Dis Clin North Am. 2008 Dec;22(4):653-663. doi: 10.1016/j.idc.2008.05.005.

    PubMed 18954757
  • Kjolhede P, Halili S, Lofgren M. Vaginal cleansing and postoperative infectious morbidity in vaginal hysterectomy. A register study from the Swedish National Register for Gynecological Surgery. Acta Obstet Gynecol Scand. 2011 Jan;90(1):63-71. doi: 10.1111/j.1600-0412.2010.01023.x. Epub 2010 Nov 26.

    PubMed 21275917
  • Steiner HL, Strand EA. Surgical-site infection in gynecologic surgery: pathophysiology and prevention. Am J Obstet Gynecol. 2017 Aug;217(2):121-128. doi: 10.1016/j.ajog.2017.02.014. Epub 2017 Feb 14.

    PubMed 28209490
  • Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after hernia surgery. BMJ. 1992 Feb 22;304(6825):469-71. doi: 10.1136/bmj.304.6825.469.

    PubMed 1547415

Questions about this trial

What is this clinical trial studying?

A study testing Betadine, Peridex and TechniCare in people with Surgical Site Infection and Vaginal Surgery, run by Wright State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 30 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Apr 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vaginal Colony Counts (Anaerobic) (time frame: 2 timepoints: prior to surgical prep, and 10 min after surgical prep). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03854370, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in